Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236781 · ClinicalTrials.gov registry record · NA
Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates
A NA study, sponsored by American College of Radiology.
- Completed
- Registry status
- NA
- Development phase
- 558
- Enrollment target
NCT01236781 is a NA study that has completed, run by American College of Radiology. The registered enrollment target is 558 participants.
The verdict
NCT01236781, a NA study, has completed, sponsored by American College of Radiology.
- COMPLETED
- Registry status
- NA
- Development phase
- 558 participants
- Enrollment target
Study Summary
This multicenter trial using Hologic digital mammography units will evaluate the specificity of 2-D full field digital mammography (FFDM) versus a combination of 2-D and 3-D tomosynthesis imaging in breast cancer screening. Specificity, in this study, will be measured by the participant call-back rate by each modality. Varying combinations of 2-D mammography and tomosynthesis projections will be evaluated to optimize the screening paradigm and limit radiation exposure when tomosynthesis is incorporated. Both prospective and retrospective imaging data will be assessed. Hypothesis: Digital breast tomography (DBT) will improve the specificity of breast cancer screening as measured by a reduction in the call-back rate while maintaining the sensitivity of cancer detection. This improved accuracy will be achieved by the optimization of the imaging sequence and number of views obtained at a capped radiation dose in the combined DBT and 2-D screening sequence.
Interventions
- DEVICE Screening Tomosynthesis
- DEVICE Diagnostic Tomosynthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 558 participants |
| Start Date | 2011-01-04 |
| Est. Completion | 2013-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01236781
The ClinicalTrials.gov registry entry for NCT01236781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 558 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American College of Radiology, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Screening Tomosynthesis is the first listed.
NCT01236781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01236781 about?
NCT01236781 is a clinical study titled "Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates". This multicenter trial using Hologic digital mammography units will evaluate the specificity of 2-D full field digital mammography (FFDM) versus a combination of 2-D and 3-D tomosynthesis imaging in breast cancer screening. Specificity, in this study, will be measured by the participant call-back ra...
What is the current status of trial NCT01236781?
This trial is currently completed. It is a NA study. The enrollment target is 558 participants. The study started on 2011-01-04. Estimated completion is 2013-12-31.
What interventions are being tested in trial NCT01236781?
The interventions under investigation include: Screening Tomosynthesis (DEVICE), Diagnostic Tomosynthesis (DEVICE).
Who is sponsoring clinical trial NCT01236781?
This trial is sponsored by American College of Radiology, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.